Compare HURA & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HURA | SUNS |
|---|---|---|
| Founded | 2009 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.0M | 108.7M |
| IPO Year | 2010 | 2024 |
| Metric | HURA | SUNS |
|---|---|---|
| Price | $1.72 | $6.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $8.04 | ★ $10.25 |
| AVG Volume (30 Days) | ★ 366.5K | 79.8K |
| Earning Date | 11-17-2026 | 11-10-2026 |
| Dividend Yield | N/A | ★ 17.86% |
| EPS Growth | ★ 47.93 | N/A |
| EPS | N/A | ★ 0.54 |
| Revenue | N/A | ★ $21,571,434.00 |
| Revenue This Year | N/A | $91.54 |
| Revenue Next Year | N/A | $12.74 |
| P/E Ratio | ★ N/A | $12.43 |
| Revenue Growth | N/A | ★ 102.96 |
| 52 Week Low | $0.41 | $5.77 |
| 52 Week High | $3.43 | $10.45 |
| Indicator | HURA | SUNS |
|---|---|---|
| Relative Strength Index (RSI) | 37.99 | 54.43 |
| Support Level | $1.27 | $6.20 |
| Resistance Level | $2.22 | $7.90 |
| Average True Range (ATR) | 0.19 | 0.27 |
| MACD | -0.02 | 0.09 |
| Stochastic Oscillator | 0.86 | 80.00 |
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS, and debt-like preferred equity securities across CRE asset classes and investment mix to include high-quality multi-family, condominiums, retail, office, hospitality, industrial, mixed-use, and specialty-use real estate. The company's portfolio is concentrated in the Southern U.S.